Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05349669Phase 2Completed
Phase 2, randomised trial (2 arms), sponsored by Anthea Hospital. Primary endpoints: Serum Cytokine Levels (IL-2, IL-6, TNF-alpha, IFN gamma), Hemodynamic Support Requirements and 2 more. Started May 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05349669.